Steroid Pulse Therapy for Children With Intravenous Immunoglobulin Therapy–Resistant Kawasaki Disease: A Prospective Study
- 27 November 2012
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 34 (4) , 959-963
Abstract
Patients with Kawasaki disease (KD) who did not respond to the initial IVIG are known to have higher risk for developing coronary arterial lesions (CALs). Our aim is to clarify whether patients with initial IVIG resistant KD may benefit from methylprednisolone pulse therapy (MPT) in comparison with re- treatment of IVIG (2nd IVIG). A total of 237 patients (median age: 2 years 2 months; range 1 months–10 years) with KD were initially treated with IVIG (2 g/kg). Among them, 41 patients (22 %) were assessed as IVIG resistance: these patients were allocated to either group A receiving MPT (n = 14) or group B receiving the 2nd IVIG (n = 27). Patients with resistant to the additional therapy (MPT or 2nd IVIG) were received second IVIG (group A) or MPT (group B). Changes in leukocyte count, C-reactive protein and albumin before and after an additional therapy were significantly greater in group A than those in group B. However, the prevalence of CALs did not differ between the groups (36 % in group A and 26 % in group B, p > 0.05). There was no significant difference in the medical cost between the groups (median cost: 92,032 JPY in group A and 97,331 JPY in group B). MPT does not reduce the risk of development to CAL and does not seem to be beneficial as single agent therapy for IVIG resistant KD.Keywords
This publication has 15 references indexed in Scilit:
- The strategy of immune globulin resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapyJournal of Cardiology, 2009
- Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulinEuropean Journal of Pediatrics, 2008
- Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki diseaseArchives of Disease in Childhood, 2007
- Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki DiseaseNew England Journal of Medicine, 2007
- A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcomeThe Journal of Pediatrics, 2006
- Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki diseaseArchives of Disease in Childhood, 2005
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Prognostic Impact of Vascular Leakage in Acute Kawasaki DiseaseCirculation, 2003
- Intravenous gamma-globulin treatment and retreatment in Kawasaki diseaseThe Pediatric Infectious Disease Journal, 1998
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984